TR199902025T2 - Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem. - Google Patents

Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem.

Info

Publication number
TR199902025T2
TR199902025T2 TR1999/02025T TR9902025T TR199902025T2 TR 199902025 T2 TR199902025 T2 TR 199902025T2 TR 1999/02025 T TR1999/02025 T TR 1999/02025T TR 9902025 T TR9902025 T TR 9902025T TR 199902025 T2 TR199902025 T2 TR 199902025T2
Authority
TR
Turkey
Prior art keywords
water
preparing
active ingredient
highly insoluble
preparation
Prior art date
Application number
TR1999/02025T
Other languages
English (en)
Turkish (tr)
Inventor
Cavallo Giovanni
Marchitto Leonardo
Original Assignee
Aziende Chimiche Riunite Angelini Francesco
A.C.R.A.F.S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco, A.C.R.A.F.S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco
Publication of TR199902025T2 publication Critical patent/TR199902025T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR1999/02025T 1997-02-20 1998-02-12 Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem. TR199902025T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000362A IT1289938B1 (it) 1997-02-20 1997-02-20 Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e

Publications (1)

Publication Number Publication Date
TR199902025T2 true TR199902025T2 (xx) 1999-11-22

Family

ID=11376097

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02025T TR199902025T2 (xx) 1997-02-20 1998-02-12 Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem.

Country Status (25)

Country Link
US (1) US6319517B1 (https=)
EP (1) EP0981332B1 (https=)
JP (1) JP4290767B2 (https=)
KR (1) KR100496802B1 (https=)
CN (1) CN1089581C (https=)
AR (1) AR011681A1 (https=)
AT (1) ATE285754T1 (https=)
AU (1) AU744115B2 (https=)
BG (1) BG64580B1 (https=)
CA (1) CA2288958C (https=)
CZ (1) CZ295998B6 (https=)
DE (1) DE69828394T2 (https=)
EA (1) EA001637B1 (https=)
ES (1) ES2235320T3 (https=)
GE (1) GEP20022734B (https=)
HU (1) HU225593B1 (https=)
IL (1) IL131327A (https=)
IT (1) IT1289938B1 (https=)
PL (1) PL190628B1 (https=)
PT (1) PT981332E (https=)
SK (1) SK282931B6 (https=)
TR (1) TR199902025T2 (https=)
UA (1) UA70296A (https=)
WO (1) WO1998036736A1 (https=)
ZA (1) ZA981352B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762944B2 (en) 1999-06-23 2003-07-10 Cornell Research Foundation Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
EP1592430A4 (en) * 2003-01-17 2006-05-31 Threshold Pharmaceuticals Inc TREATMENT OF GOOD PROSTATE HYPERPLASIA BY MEANS OF ENERGYSTIC ACTIVE SUBSTANCES
US7825087B2 (en) 2005-04-12 2010-11-02 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising cyclosporine
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
CN101049504B (zh) * 2007-04-05 2010-05-19 广州立恩生物科技有限公司 一种脂质体药物载体及其制备方法
US9446147B2 (en) 2011-02-24 2016-09-20 The Ohio State University Membrane stabilizing compositions and methods
EP3572071A1 (en) 2011-10-21 2019-11-27 Jazz Pharmaceuticals Research LLC Lyophilized liposomes
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
JP5957610B2 (ja) * 2012-08-31 2016-07-27 チュンアン ユニバーシティー インダストリー アカデミック コアポレイション ファウンデイション 塞栓用のミクロスフェアの製造方法及び薬物含有ナノ輸送体が結合されたミクロスフェアの製造方法
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
KR102649069B1 (ko) 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
IL279760B2 (en) 2018-06-27 2025-10-01 Breath Therapeutics Gmbh Pharmaceutical preparations in lyophilized form
CA3104443A1 (en) * 2018-06-27 2020-01-02 Breath Therapeutics Gmbh Inhalable compositions comprising macrocyclic immunosuppressants
JP7079984B2 (ja) 2018-07-28 2022-06-03 エクソコバイオ インコーポレイテッド エキソソームの凍結乾燥方法
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN111358955B (zh) * 2020-04-01 2023-05-02 重庆理工大学 一种用于治疗脂质代谢疾病的炎症靶向的宾达利纳米粒、制备方法及其应用
JP7508359B2 (ja) * 2020-12-11 2024-07-01 株式会社東芝 脂質粒子の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
FR2542749B1 (fr) * 1983-03-18 1985-07-12 Beghin Say Sa Copolymere allyloligosaccharide-acrylique salifie, procede de preparation du copolymere et application comme super-absorbant
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AU683957B2 (en) * 1993-11-05 1997-11-27 Amgen, Inc. Liposome preparation and material encapsulation method

Also Published As

Publication number Publication date
HU225593B1 (en) 2007-05-02
DE69828394T2 (de) 2005-12-08
EP0981332B1 (en) 2004-12-29
JP4290767B2 (ja) 2009-07-08
KR20000075479A (ko) 2000-12-15
EP0981332A1 (en) 2000-03-01
WO1998036736A1 (en) 1998-08-27
EA199900751A1 (ru) 2000-10-30
UA70296C2 (uk) 2004-10-15
CZ292599A3 (cs) 2000-01-12
IL131327A (en) 2004-07-25
HK1026148A1 (en) 2000-12-08
AU744115B2 (en) 2002-02-14
UA70296A (uk) 2004-10-15
AR011681A1 (es) 2000-08-30
ZA981352B (en) 1998-08-19
JP2001519776A (ja) 2001-10-23
ITMI970362A1 (it) 1998-08-20
AU6496998A (en) 1998-09-09
CA2288958A1 (en) 1998-08-27
ES2235320T3 (es) 2005-07-01
GEP20022734B (en) 2002-07-25
ATE285754T1 (de) 2005-01-15
BG64580B1 (bg) 2005-08-31
CN1089581C (zh) 2002-08-28
CA2288958C (en) 2007-08-21
IL131327A0 (en) 2001-01-28
PT981332E (pt) 2005-05-31
HUP0001464A3 (en) 2001-12-28
PL190628B1 (pl) 2005-12-30
CZ295998B6 (cs) 2005-12-14
CN1248163A (zh) 2000-03-22
DE69828394D1 (de) 2005-02-03
EA001637B1 (ru) 2001-06-25
SK282931B6 (sk) 2003-01-09
SK111099A3 (en) 2000-05-16
US6319517B1 (en) 2001-11-20
HUP0001464A2 (hu) 2000-10-28
PL335207A1 (en) 2000-04-10
BG103738A (en) 2000-05-31
KR100496802B1 (ko) 2005-06-22
IT1289938B1 (it) 1998-10-19

Similar Documents

Publication Publication Date Title
TR199902025T2 (xx) Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem.
DK74187A (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
ATE244015T1 (de) Formulierungen fuer faktor ix
ES2171883T3 (es) Procedimiento para la preparacion de formulaciones de agentes tensioactivos pulmonares en forma de polvos.
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
EP1686172A3 (en) Myocardial grafts and cellular compositions useful for same
NO178687C (no) Fremgangsmåte for fremstilling av forenlige, lagringsstabile erythropoietinpreparater
DK0454044T3 (da) Farmakologisk præparat indeholdende polyelektrolytkomplekser på mikropartikelform og mindst et virksomt stof
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
EP1100522A4 (en) ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
CA2213861A1 (en) Method for loading lipid vesicles
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
BR0316402A (pt) vesìcula fusogênica, métodos para preparar uma vesìcula fusogênica encapsulante, e para encapsular pelo menos uma substáncia terapêutica ou imunologicamente ativa em uma vesìcula fusogênica, uso de uma vesìcula fusogênica, e, formulação farmacêutica
FR2763943B1 (fr) Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
IT1196484B (it) Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe
WO1997031934A3 (de) Neue metabolisierbare lipopolyamine, deren darstellung und anwendung
CA2191750A1 (en) Virosome-mediated intracellular delivery of therapeutic agents
ATE208369T1 (de) Neue lipopolyamine, deren darstellung und anwendung
EP0800822A3 (en) Method for preparing closed vesicles by rehydration of dehydrated vesicles
ATE26109T1 (de) Acetylcystein-salze, ihre herstellung und verwendung.
CA2004387A1 (en) Cyclosporine binding protein and use in an assay for biologically-active cyclosporine
Bicknell et al. Mechanism of action of somatostatin: growth-hormone release [45Ca] calcium ion efflux and cyclic nucleotide metabolism of bovine anterior-pituitary slices in the presence of prostaglandin E2 and 1-methyl-3-isobutylxanthine